These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Recent advances in the diagnosis and management of amyloid cardiomyopathy. Nijst P; Tang WW Fac Rev; 2021; 10():31. PubMed ID: 33817700 [TBL] [Abstract][Full Text] [Related]
10. Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature. Adam RD; Coriu D; Jercan A; Bădeliţă S; Popescu BA; Damy T; Jurcuţ R ESC Heart Fail; 2021 Aug; 8(4):2380-2396. PubMed ID: 34089308 [TBL] [Abstract][Full Text] [Related]
13. Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis. Fine NM; Davis MK; Anderson K; Delgado DH; Giraldeau G; Kitchlu A; Massie R; Narayan J; Swiggum E; Venner CP; Ducharme A; Galant NJ; Hahn C; Howlett JG; Mielniczuk L; Parent MC; Reece D; Royal V; Toma M; Virani SA; Zieroth S Can J Cardiol; 2020 Mar; 36(3):322-334. PubMed ID: 32145862 [TBL] [Abstract][Full Text] [Related]
14. Transthyretin cardiac amyloidosis: an update on diagnosis and treatment. Yamamoto H; Yokochi T ESC Heart Fail; 2019 Dec; 6(6):1128-1139. PubMed ID: 31553132 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis. Brownrigg J; Lorenzini M; Lumley M; Elliott P ESC Heart Fail; 2019 Oct; 6(5):1041-1051. PubMed ID: 31487121 [TBL] [Abstract][Full Text] [Related]
19. A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis. Kreusser MM; Volz MJ; Knop B; Ehlermann P; Schmack B; Ruhparwar A; Hegenbart U; Schönland SO; Katus HA; Raake PW Clin Res Cardiol; 2020 Jun; 109(6):700-713. PubMed ID: 31630214 [TBL] [Abstract][Full Text] [Related]